Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-book ratio

Latest
2.38
↑ 242% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-1.67
Historical baseline
PeriodValueYoY Change
20242.38+89.6%
20231.25+114.5%
2022-8.64-